Companies Dominating the Global Mycoplasma Testing Landscape
- Thermo Fisher Scientific, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck KGaA
- Lonza Group Ltd.
- PromoCell GmbH
- Asahi Kasei Corporation
- Sartorius AG
- InvivoGen
- Eurofins Scientific
- SwiftDx
- Agathos Biologics
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Mycoplasma Testing Market in 2025 is estimated at USD 1.2 billion.
The global market size was valued at around USD 1.09 billion in 2024 and is projected to grow at a CAGR of more than 12.5%, reaching USD 5.04 billion revenue by 2037.
North America is set to attain USD 1.86 billion by 2037, fueled by presence of biotech and pharmaceutical companies and increased investment in R&D for new drugs and therapies.
The major players in the market include Thermo Fisher Scientific, Inc., Merck KGaA, Lonza Group Ltd., PromoCell GmbH, Asahi Kasei Corporation, Sartorius AG, InvivoGen, Eurofins Scientific, SwiftDx, Agathos Biologics.
